Business Description
Bio Plus Co Ltd
ISIN : KR7099430001
Compare
Compare
Traded in other countries / regions
099430.Korea IPO Date
2021-09-27Description
Bio Plus Co Ltd is engaged in the development of innovative biomedical and medical devices products through research on bio-material applications platform technology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.91 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | 125.67 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.51 | |||||
| Beneish M-Score | -3.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.4 | |||||
| 3-Year EBITDA Growth Rate | 32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 30.4 | |||||
| 3-Year Book Growth Rate | 59.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.33 | |||||
| 9-Day RSI | 40.61 | |||||
| 14-Day RSI | 40.07 | |||||
| 6-1 Month Momentum % | -15.04 | |||||
| 12-1 Month Momentum % | -17.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.95 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 1.07 | |||||
| Days Inventory | 133.62 | |||||
| Days Sales Outstanding | 119.11 | |||||
| Days Payable | 13.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.35 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| Forward Dividend Yield % | 1.35 | |||||
| 5-Year Yield-on-Cost % | 1.34 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 0.47 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.04 | |||||
| Operating Margin % | 34.61 | |||||
| Net Margin % | 36.67 | |||||
| FCF Margin % | -58.87 | |||||
| ROE % | 16.05 | |||||
| ROA % | 11.74 | |||||
| ROIC % | 16.11 | |||||
| 3-Year ROIIC % | 17 | |||||
| ROC (Joel Greenblatt) % | 34.89 | |||||
| ROCE % | 17.22 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.2 | |||||
| Forward PE Ratio | 12.9 | |||||
| PE Ratio without NRI | 20.63 | |||||
| Price-to-Owner-Earnings | 13.94 | |||||
| PEG Ratio | 0.72 | |||||
| PS Ratio | 5.55 | |||||
| PB Ratio | 2.27 | |||||
| Price-to-Tangible-Book | 2.39 | |||||
| Price-to-Operating-Cash-Flow | 11.84 | |||||
| EV-to-EBIT | 10.04 | |||||
| EV-to-EBITDA | 9.05 | |||||
| EV-to-Revenue | 4.89 | |||||
| EV-to-FCF | -8.35 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
| Price-to-Graham-Number | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 28.67 | |||||
| Earnings Yield (Greenblatt) % | 9.96 | |||||
| FCF Yield % | -10.97 | |||||
| Forward Rate of Return (Yacktman) % | 18.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio Plus Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 54,581.256 | ||
| EPS (TTM) (â‚©) | 342 | ||
| Beta | 1.27 | ||
| Volatility % | 48.42 | ||
| 14-Day RSI | 40.07 | ||
| 14-Day ATR (â‚©) | 227.161301 | ||
| 20-Day SMA (â‚©) | 5302.5 | ||
| 12-1 Month Momentum % | -17.68 | ||
| 52-Week Range (â‚©) | 4250 - 7450 | ||
| Shares Outstanding (Mil) | 56.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio Plus Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio Plus Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio Plus Co Ltd Frequently Asked Questions
What is Bio Plus Co Ltd(XKRX:099430)'s stock price today?
The current price of XKRX:099430 is â‚©5200.00. The 52 week high of XKRX:099430 is â‚©7450.00 and 52 week low is â‚©4250.00.
When is next earnings date of Bio Plus Co Ltd(XKRX:099430)?
The next earnings date of Bio Plus Co Ltd(XKRX:099430) is .
Does Bio Plus Co Ltd(XKRX:099430) pay dividends? If so, how much?
The Dividend Yield %  of Bio Plus Co Ltd(XKRX:099430) is 1.35% (As of Today), Highest Dividend Payout Ratio of Bio Plus Co Ltd(XKRX:099430) was 0.28. The lowest was 0.17. And the median was 0.18. The  Forward Dividend Yield % of Bio Plus Co Ltd(XKRX:099430) is 1.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers